<VariationArchive VariationID="3243061" VariationName="NC_000017.10:g.(?_68166871)_(68171602_?)del" VariationType="Deletion" Accession="VCV003243061" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3401658" VariationID="3243061">
      <GeneList>
        <Gene Symbol="KCNJ2" FullName="potassium inwardly rectifying channel subfamily J member 2" GeneID="3759" HGNC_ID="HGNC:6263" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="70169532" stop="70180044" display_start="70169532" display_stop="70180044" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="68165675" stop="68176184" display_start="68165675" display_stop="68176184" Strand="+" />
          </Location>
          <OMIM>600681</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000017.10:g.(?_68166871)_(68171602_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" innerStart="68166871" innerStop="68171602" display_start="68166871" display_stop="68171602" variantLength="4732" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.(?_68166871)_(68171602_?)del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.(?_68166871)_(68171602_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000017.10:g.(?_68166871)_(68171602_?)del AND multiple conditions" Accession="RCV004581299" Version="1">
        <ClassifiedConditionList TraitSetID="9142">
          <ClassifiedCondition DB="MedGen" ID="C1563715">Andersen Tawil syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1865018">Short QT syndrome type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12163457</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19862833</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22166941</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22186697</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9142" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="244" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Andersen Tawil syndrome</ElementValue>
                <XRef ID="Andersen+Tawil+Syndrome/431" DB="Genetic Alliance" />
                <XRef ID="422348008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen cardiodysrhythmic periodic paralysis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Long QT syndrome 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Periodic paralysis, potassium-sensitive cardiodysrhythmic type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ATS</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LQT7</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9453" />
                <XRef ID="9453" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Andersen-Tawil syndrome (ATS) is characterized by a triad of: episodic flaccid muscle weakness (i.e., periodic paralysis); ventricular arrhythmias and prolonged QT interval; and anomalies including low-set ears, widely spaced eyes, small mandible, fifth-digit clinodactyly, syndactyly, short stature, and scoliosis. Affected individuals present in the first or second decade with either cardiac symptoms (palpitations and/or syncope) or weakness that occurs spontaneously following prolonged rest or following rest after exertion. Mild permanent weakness is common. Mild learning difficulties and a distinct neurocognitive phenotype (i.e., deficits in executive function and abstract reasoning) have been described.</Attribute>
                <XRef ID="NBK1264" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301441</ID>
                <ID Source="BookShelf">NBK1264</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="37553" DB="Orphanet" />
              <XRef ID="C1563715" DB="MedGen" />
              <XRef ID="MONDO:0008222" DB="MONDO" />
              <XRef Type="MIM" ID="170390" DB="OMIM" />
            </Trait>
            <Trait ID="3722" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Short QT syndrome type 3</ElementValue>
                <XRef ID="MONDO:0012314" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SQT3</ElementValue>
                <XRef Type="MIM" ID="609622" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18635" />
                <XRef ID="18635" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <XRef ID="51083" DB="Orphanet" />
              <XRef ID="C1865018" DB="MedGen" />
              <XRef ID="MONDO:0012314" DB="MONDO" />
              <XRef Type="MIM" ID="609622" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9833550" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000017.10:g.(?_68166871)_(68171602_?)del|MedGen:C1865018;C1563715" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005065393" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12163457</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19862833</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22166941</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22186697</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in KCNJ2 are known to be pathogenic (PMID: 12163457, 19862833, 22166941, 22186697). This variant has not been reported in the literature in individuals with KCNJ2-related conditions. This variant is a deletion of the genomic region encompassing part of exon 2 (c.-217+1029_422del) of the KCNJ2 gene. This is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.(?_68166871)_(68171602_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1865018" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1563715" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9833550" TraitType="Disease" MappingType="XRef" MappingValue="C1865018" MappingRef="MedGen">
        <MedGen CUI="C1865018" Name="Short QT syndrome type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9833550" TraitType="Disease" MappingType="XRef" MappingValue="C1563715" MappingRef="MedGen">
        <MedGen CUI="C1563715" Name="Andersen Tawil syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

